Cellularline Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Cellularline has a total shareholder equity of €130.3M and total debt of €36.1M, which brings its debt-to-equity ratio to 27.7%. Its total assets and total liabilities are €215.6M and €85.4M respectively. Cellularline's EBIT is €6.9M making its interest coverage ratio 2.6. It has cash and short-term investments of €11.9M.
Anahtar bilgiler
27.7%
Borç/özkaynak oranı
€36.06m
Borç
Faiz karşılama oranı | 2.6x |
Nakit | €11.93m |
Eşitlik | €130.27m |
Toplam yükümlülükler | €85.36m |
Toplam varlıklar | €215.64m |
Son finansal sağlık güncellemeleri
Is Cellularline (BIT:CELL) Using Too Much Debt?
May 10Is Cellularline (BIT:CELL) A Risky Investment?
May 25Recent updates
Is Cellularline (BIT:CELL) Using Too Much Debt?
May 10Is Cellularline (BIT:CELL) A Risky Investment?
May 25At €4.58, Is Cellularline S.p.A. (BIT:CELL) Worth Looking At Closely?
Apr 29Some Investors May Be Worried About Cellularline's (BIT:CELL) Returns On Capital
Apr 04Do Institutions Own Cellularline S.p.A. (BIT:CELL) Shares?
Mar 14Does Cellularline's (BIT:CELL) Statutory Profit Adequately Reflect Its Underlying Profit?
Feb 21A Look At The Intrinsic Value Of Cellularline S.p.A. (BIT:CELL)
Feb 06Is There Now An Opportunity In Cellularline S.p.A. (BIT:CELL)?
Jan 21Should You Buy Cellularline S.p.A. (BIT:CELL) For Its Dividend?
Jan 06Reflecting on Cellularline's (BIT:CELL) Share Price Returns Over The Last Year
Dec 22How Much Of Cellularline S.p.A. (BIT:CELL) Do Insiders Own?
Dec 11Not Many Are Piling Into Cellularline S.p.A. (BIT:CELL) Just Yet
Nov 29Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: CELL's short term assets (€113.4M) exceed its short term liabilities (€69.7M).
Uzun Vadeli Yükümlülükler: CELL's short term assets (€113.4M) exceed its long term liabilities (€15.6M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: CELL's net debt to equity ratio (18.5%) is considered satisfactory.
Borcun Azaltılması: CELL's debt to equity ratio has reduced from 33% to 27.7% over the past 5 years.
Borç Kapsamı: CELL's debt is well covered by operating cash flow (66.9%).
Faiz Kapsamı: CELL's interest payments on its debt are not well covered by EBIT (2.6x coverage).